Search

everythinglearnresearchcommunity

for

Search:↓

Platelet-rich plasma is a promising and safe treatment for increasing hair density and thickness in women with chronic telogen effluvium.

Alpha-tocopherol does not prevent hair loss from doxorubicin.

Combination therapy, including JAK inhibitors, effectively regrows hair and reduces severity in Black children with stubborn Alopecia Areata.

Plum-blossom needling with conventional treatments improves hair regrowth in alopecia areata.

RCS-01 therapy is safe and may improve skin structure by affecting gene expression.

Diphenylcyclopropenone treatment helps prevent hair loss relapse in alopecia areata patients.

JAK inhibitors are a promising new treatment for hair loss and nail problems in alopecia areata.

Azathioprine may be an effective treatment for severe hair loss.

Astaxanthin is a safe antioxidant that may improve heart, skin, eye health, and physical performance, and help manage chronic diseases.

Trastuzumab deruxtecan is effective for HER2-positive breast cancer but requires careful management of side effects.

Upadacitinib is safe and effective for treating alopecia areata and atopic dermatitis in children.

JAK inhibitors are safe and effective for treating moderate-to-severe alopecia areata.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

The oral supplement improved hair loss in patients with telogen effluvium.

Simvastatin/ezetimibe may help some patients with severe alopecia areata regrow hair.

Testosterone with finasteride improved muscle and bone health in men with spinal cord injury.

ViviScal®, a food supplement, was found to be highly effective in treating hereditary hair loss in young males, while fish extract showed no impact.

PRP therapy effectively improves hair density and reduces hair loss in androgenetic alopecia.

Dabrafenib was effective and well tolerated in treating thyroid cancer with a specific mutation.

New treatment combining PRP and SVF increases hair density in 6-12 weeks for androgenetic alopecia patients.

IVL3001 is safe, effective, and better than oral finasteride for treating hair loss.

A personalized combination treatment can effectively promote hair growth and stabilize hair loss in women with androgenetic alopecia.

PRP therapy improves hair density and thickness in AGA patients, even with other treatments.

Minoxidil and ATRA together boost hair growth more effectively than minoxidil alone.

Flutamide, an oral anti-androgen therapy, is effective in treating female pattern hair loss, even without systemic androgen excess.

Brepocitinib effectively reduces inflammation and improves symptoms in cicatricial alopecia with good safety.

Auranofin shows promise as a cancer treatment, especially when combined with other therapies.

Testosterone with dutasteride improves muscle strength and body composition in trans men.

Using both minoxidil and finasteride together is more effective for hair growth than using either one alone in men with hair loss.